Negative thermo-responsive microspheres based on hydrolyzed gelatin as drug delivery device.
This paper deals with the synthesis of thermo-responsive microspheres with proteic structure exhibiting a transition temperature close to the body temperature. Temperature-sensitive hydrogels have attracted extensive interest due to their potential and promising applications in drug delivery field since they can undergo a rapid and reversible phase transition from a swollen to a shrunken state depending on environmental temperature. The hydrogels were synthesized by free-radical polymerization of hydrolyzed methacrylated gelatin (HGel-MA) and N,N'-methylenebisacrylamide as pro-hydrophilic multifunctional macromer and crosslinker, respectively, and N-isopropylacrylamide as thermo-responsive monomer. Thermal analyses showed negative thermo-responsive behavior for all compositions and, by increasing the content of the hydrophilic moieties in the network, the transition temperature raised to 36.9 degrees C, close to the physiological values. In order to test the materials as drug carriers, diclofenac sodium salt was chosen as model drug. Drug release profiles, in phosphate buffer solution (pH 7.0, 10(-3) M) at 25 and 40 degrees C, depend on the hydrogel's crosslinking degree and hydrophilic/hydrophobic balance in the polymeric network. For all formulations, in the shrunken state, the drug release percent values ranged from 80% to 100% after 24 h, and after 3 h, more than 60% of therapeutics was delivered. On the contrary, the swelling of the loaded microparticles produces, even after 30 h, a drug release percent of about 75%. By using semi-empirical equations, the release mechanism was extensively studied and the diffusional contribute was evaluated. The physico-chemical characteristics of thermo-responsive materials confirm the applicability of the microspheres as drug delivery device.
Curcio
Manuela
M
Pharmaceutical Science Department, University of Calabria, Edificio Polifunzionale, Rende, (CS), Italy.
Puoci
Francesco
F
Spizzirri
U Gianfranco
UG
Iemma
Francesca
F
Cirillo
Giuseppe
G
Parisi
Ortensia I
OI
Picci
Nevio
N
D002214:Capsules; D004008:Diclofenac / Q000737:chemistry*; D004058:Diffusion; D004339:Drug Compounding / Q000379:methods; D004355:Drug Stability; D005079:Excipients / Q000737:chemistry*; D005780:Gelatin / Q000737:chemistry*; D006358:Hot Temperature; D006868:Hydrolysis; D014677:Pharmaceutical Vehicles / Q000737:chemistry*
D002214:Capsules; D005079:Excipients; D014677:Pharmaceutical Vehicles; D004008:Diclofenac; D005780:Gelatin
J Control Release. 2014 Sep 28;190:31-2
25356469
J Biomater Sci Polym Ed. 2004;15(2):125-44
15109093
Science. 2004 Sep 24;305(5692):1923-4
15448260
Eur J Pharm Biopharm. 2000 Jul;50(1):27-46
10840191
Expert Opin Drug Deliv. 2008 Oct;5(10):1077-91
18817514
Pharm Res. 2006 Jan;23(1):205-14
16270162
Eur J Pharm Biopharm. 2008 Jan;68(1):34-45
17881200
J Drug Target. 2009 Jan;17(1):72-7
19016107
Adv Drug Deliv Rev. 2001 Dec 31;53(3):321-39
11744175
Chem Soc Rev. 2005 Mar;34(3):276-85
15726163
J Mater Sci Mater Med. 2007 Jun;18(6):1089-96
17268868
Int J Pharm. 2006 Apr 7;312(1-2):151-7
16490328
Adv Drug Deliv Rev. 2006 Dec 30;58(15):1655-70
17125884
J Control Release. 1998 Dec 4;56(1-3):149-58
9801438
Biomed Mater. 2009 Apr;4(2):022001
19261988
Nature. 2004 Apr 1;428(6982):487-92
15057821